Background: Determining optimal timing for intensifying the frequency of physician encounters for type 2 diabetes mellitus (T2DM) requires trade-offs between timely care and clinician burden. We aimed ...

Immuneering Corporation - Special CallCompany ParticipantsBenjamin Zeskind - Co-Founder, President, CEO & DirectorConference Call ...

Masimo (NASDAQ: MASI) today announced the findings of a study published in the Journal of Patient Safety in which Dr. George ...

Long-term follow-up data for daraxonrasib monotherapy in second line metastatic pancreatic ductal adenocarcinoma reinforces ...

The US Scenario Modeling Hub’s nine-team ensemble projected COVID-19 hospitalizations and deaths for April 2024 to April 2025 ...

The Real Estate Debt Fund launched March 31, 2025. Institutional shares returned 2.02% during the second quarter, and the ...

Starbucks CEO Brian Niccol made $95.8 million in 2024, while the median barista at the company made just $14,674, according to the AFL-CIO. The CEO-to-worker pay ratio of 6,666-to-1 is the largest ...

Utilizing market research to inform decision-making begins with clearly identifying the objective: What specific goal am I ...

Li-Fraumeni syndrome (LFS) is a high-risk hereditary cancer predisposition syndrome affecting 1 in 5000 individuals. Current ...

Objective This study examined the patterns and persistence of SARS-CoV-2 seropositivity among college students from March to ...

EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study In phase 2a study, brivekimig led to clinically meaningful improvements in primary and key secondary ...